Fen Lai Tan
Director/Miembro de la Junta en Capio Biosciences, Inc. .
Perfil
Fen Lai Tan is currently a Director at Capio Biosciences, Inc. Prior to this, he worked as a Director, Chief Medical Officer & Senior VP at Betta Pharmaceuticals Co., Ltd.
from 2013 to 2018.
Dr. Tan holds a doctorate degree from The University of Arkansas.
Cargos activos de Fen Lai Tan
Empresas | Cargo | Inicio |
---|---|---|
Capio Biosciences, Inc.
Capio Biosciences, Inc. BiotechnologyHealth Technology Capio Biosciences, Inc. operates as biotech company, designs and develops OncoSense CTC technology that removes circulating tumor cells from a patient's liquid biopsy. The company was founded in 2015 by Seungpyo Hong and Andrew Wang and is headquartered in Madison, WI. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Fen Lai Tan.
Empresas | Cargo | Fin |
---|---|---|
BETTA PHARMACEUTICALS CO., LTD. | Director Técnico/Científico/I+D | 26/03/2018 |
Formación de Fen Lai Tan.
The University of Arkansas | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BETTA PHARMACEUTICALS CO., LTD. | Health Technology |
Empresas privadas | 1 |
---|---|
Capio Biosciences, Inc.
Capio Biosciences, Inc. BiotechnologyHealth Technology Capio Biosciences, Inc. operates as biotech company, designs and develops OncoSense CTC technology that removes circulating tumor cells from a patient's liquid biopsy. The company was founded in 2015 by Seungpyo Hong and Andrew Wang and is headquartered in Madison, WI. | Health Technology |
- Bolsa de valores
- Insiders
- Fen Lai Tan